Skip to Main Content

PrecISE: Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network

Conditions

Asthma

Phase II

What is the purpose of this trial?

Researchers at Yale University are conducting a study to find new treatments for severe asthma that is sponsored by the National Institutes of Health

The Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network Study (“PrecISE”) is screening people with severe asthma. You may be eligible to participate in the PrecISE Study if you meet certain criteria.

Multiple treatments will be tested in a placebo controlled randomized trial. Each participant will participate in at least 2 treatment periods (up to 5 treatment periods).

  • Trial with
    University of North Carolina at Chapel Hill
  • Start Date
    08/21/2020
  • End Date
    06/30/2023

For more information about this study, contact:

Jean Estrom, RN

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    07/15/2021
  • Study HIC
    #2000026205